OTC · Financial Statements

Immunotech Laboratories, Inc. (IMMB) Financial Statements

$0.00 OTC: IMMB Market Cap $114993

Immunotech Laboratories, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20042005200920132016
Revenue$0$0$0$0$0
Operating Profit$0$-2.0M$-1.0M$-1.0M$0
Net Profit$0$-34.0M$-1.0M$-1.0M$0
EPS$-43.00$-802.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20042005200920132016
Total Assets$0$0$10.0M$11.0M$11.0M
Total Liabilities$1.0M$1.0M$4.0M$5.0M$6.0M
Cash$0$0$0$0$0
Borrowings$0$0$1.0M$2.0M$2.0M

Cash Flow (USD)

Metric20042005200920132016
Operating Cash Flow$0$0—$0$0
Investing Cash Flow$0$0—$0$0
Financing Cash Flow$0$0—$0$0
Net Cash Flow$0$0—$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-5.55
FCF Yield-27.10%
Quick Ratio0.00
Interest Coverage-20.75
Return 1Y100.00%
Return 3Y-66.67%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
IMMB Overview IMMB Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.